Results

1–5 of 5 results for GuARD

Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
Christina Joy Flaxel, MD
Annual Meeting Talks
2023
Fibrin Glue–Assisted Retinopexy for Rhegmatogenous Retinal Detachments: GUARD Study; Long-Term Outcomes of a New Surgical Technique With No Silicone Oil or Gas Tamponade
Mudit Tyagi, MS, FASRS
Annual Meeting Talks
2022
Surgical Outcomes of Scleral Buckling for Rhegmatogenous Retinal Detachment Using the NGENUITY 3-Dimensional Visualization System With a Guarded Light Pipe
John B. Miller, MD
Annual Meeting Talks
2022
Fibrin Glue–Assisted Retinopexy for Rhegmatogenous Retinal Detachments: GUARD Study; Long-Term Outcomes of a New Surgical Technique With No Silicone Oil or Gas Tamponade
Mudit Tyagi, MS, FASRS
Updates from the Field
2022
Glue Assisted Retinopexy for Rhegmatogenous Retinal Detachments (GuARD): A Novel Surgical Technique for Closing Retinal Breaks
Mudit Tyagi, MS, FASRS
On Demand Cases, Courses, and Papers
2019